← Back
$RYTM All transactions

RHYTHM PHARMACEUTICALS, INC.

▼ SELL 10b5-1 Plan

$ Value

$359K

Shares

3,381

Price

$106

Filed

Feb 6

Insider

Name

Smith Hunter C

Title

Chief Financial Officer

CIK

0001636385

Roles

Officer

Transaction Details

Transaction Date

2026-02-05

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

125,537

Footnotes

The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 28, 2025. | The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $104.34 to $104.99 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $106.31 to $107.15 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $107.32 to $108.08 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Filing Info

Accession No.

0001104659-26-011651

Form Type

4

Issuer CIK

0001649904

Smith Hunter C's History

Date Ticker Type Value
2026-02-19 RYTM $131K
2026-02-19 RYTM $171K
2026-02-19 RYTM $82K
2026-02-19 RYTM $60K
2026-02-17 RYTM $119K
2026-02-17 RYTM $20K
2026-02-17 RYTM $92K
2026-02-17 RYTM $110K
2026-02-17 RYTM $21K
2026-02-12 RYTM $28K

Other Insiders at RYTM (90d)

Insider Bought Sold Last
German Christopher Paul
Corporate Controller & CAO
2026-02-11
Popovits Kimberly J 2026-04-01
Meeker David P
President and CEO
2026-02-11
Smith Hunter C
Chief Financial Officer
$1.9M 2026-02-19
Mazabraud Yann
EVP, Head of International
2026-04-01
Lee Jennifer Kayden
EVP, Head of North America
2026-02-11
Cramer Pamela J.
Chief Human Resources Officer
2026-02-11
Shulman Joseph
Chief Technical Officer
2026-02-11
Garfield Alastair
Chief Scientific Officer
2026-02-11